ResMed Inc annual operating income for fiscal TTM was $1.9 billion, an increase of 0.0% from $1.9 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | $1.9B | $1.9B | $1.7B | $1.3B | $1.1B | $1.0B | $904M | $810M | $579M | $542M | $426M | $429M | $409M | $405M | $355M | $294M | $267M | $240M | $190M | $143M | $90M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | $449M | $500M | $498M | $447M | $455M | $426M | $417M | $387M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RMD metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All RMD financial statements → Interactive RMD charts →
About TickerBase · Data methodology & sources · Privacy · Terms